Haddad N, Delyon J, Trabelsi Messai S, Herms F, et al. Clinical response to immune checkpoint inhibition in patients with advanced skin cancers receiving concurrent ruxolitinib therapy for haematological malignancy. Br J Dermatol 2021;184:564-566.
PMID: 33058221